These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease. Grafton ST; Mazziotta JC; Pahl JJ; St George-Hyslop P; Haines JL; Gusella J; Hoffman JM; Baxter LR; Phelps ME Ann Neurol; 1990 Nov; 28(5):614-21. PubMed ID: 1979723 [TBL] [Abstract][Full Text] [Related]
25. Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. A PET study. Turjanski N; Weeks R; Dolan R; Harding AE; Brooks DJ Brain; 1995 Jun; 118 ( Pt 3)():689-96. PubMed ID: 7600086 [TBL] [Abstract][Full Text] [Related]
27. A childhood form of Huntington's disease associated with marked pyramidal signs. Katafuchi Y; Fujimoto T; Ono E; Kuda N Eur Neurol; 1984; 23(4):296-9. PubMed ID: 6237914 [TBL] [Abstract][Full Text] [Related]
28. SPECT, CT and MRI in a Turkish family with Huntington's disease. Bruyn RP; Hageman G; Geelen JA; van der Weel FA; Rozeboom AR; Barkhof F; Scheltens P Neuroradiology; 1993; 35(7):525-8. PubMed ID: 8232881 [TBL] [Abstract][Full Text] [Related]
29. Elevated brain iron is independent from atrophy in Huntington's Disease. Dumas EM; Versluis MJ; van den Bogaard SJ; van Osch MJ; Hart EP; van Roon-Mom WM; van Buchem MA; Webb AG; van der Grond J; Roos RA; Neuroimage; 2012 Jul; 61(3):558-64. PubMed ID: 22480728 [TBL] [Abstract][Full Text] [Related]
30. Early grey matter changes in structural covariance networks in Huntington's disease. Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113 [TBL] [Abstract][Full Text] [Related]
34. Basal ganglia alterations and brain atrophy in Huntington's disease depicted by transcranial real time sonography. Postert T; Lack B; Kuhn W; Jergas M; Andrich J; Braun B; Przuntek H; Sprengelmeyer R; Agelink M; Büttner T J Neurol Neurosurg Psychiatry; 1999 Oct; 67(4):457-62. PubMed ID: 10486391 [TBL] [Abstract][Full Text] [Related]
35. [Anarthria, progressive apraxia and extrapyramidal syndrome: an uncommon clinical form of corticobasal degeneration? A case studied by HMPAO Tc99m single-photon emission tomography]. Fayet G; Vercelletto M; Bertout C; De Kersaint-Gilly A; Fève JR Rev Neurol (Paris); 1995 Apr; 151(4):247-50. PubMed ID: 7481375 [TBL] [Abstract][Full Text] [Related]
36. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. Antonini A; Leenders KL; Spiegel R; Meier D; Vontobel P; Weigell-Weber M; Sanchez-Pernaute R; de Yébenez JG; Boesiger P; Weindl A; Maguire RP Brain; 1996 Dec; 119 ( Pt 6)():2085-95. PubMed ID: 9010012 [TBL] [Abstract][Full Text] [Related]
37. Neuropathological Comparison of Adult Onset and Juvenile Huntington's Disease with Cerebellar Atrophy: A Report of a Father and Son. Latimer CS; Flanagan ME; Cimino PJ; Jayadev S; Davis M; Hoffer ZS; Montine TJ; Gonzalez-Cuyar LF; Bird TD; Keene CD J Huntingtons Dis; 2017; 6(4):337-348. PubMed ID: 29036832 [TBL] [Abstract][Full Text] [Related]
38. Regional specificity of brain atrophy in Huntington's disease. Halliday GM; McRitchie DA; Macdonald V; Double KL; Trent RJ; McCusker E Exp Neurol; 1998 Dec; 154(2):663-72. PubMed ID: 9878201 [TBL] [Abstract][Full Text] [Related]
39. D2 receptors in Huntington's disease: positron emission tomography findings and clinical correlates. Brandt J; Folstein SE; Wong DF; Links J; Dannals RF; McDonnell-Sill A; Starkstein S; Anders P; Strauss ME; Tune LE J Neuropsychiatry Clin Neurosci; 1990; 2(1):20-7. PubMed ID: 1983772 [TBL] [Abstract][Full Text] [Related]
40. Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes. Bäckman L; Robins-Wahlin TB; Lundin A; Ginovart N; Farde L Brain; 1997 Dec; 120 ( Pt 12)():2207-17. PubMed ID: 9448576 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]